Masters of Scale cover image

Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky

Masters of Scale

00:00

Navigating Drug Pricing Challenges

This chapter explores the struggles of a new pharmaceutical company in securing partnerships with traditional manufacturers due to industry pressures. It highlights the case of albendazole to illustrate the potential for reduced drug costs and critiques the role of Pharmacy Benefit Managers in contributing to inflated prices.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app